Related Experiment Video
Updated: Jul 20, 2026

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
Published on: December 20, 2024
Management of ampullary lesions
George W Dittrick1, Damien B Mallat, Jeffrey P Lamont
1Department of Surgery, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246, USA. jeffreyl@baylorhealth.edu.
Management of ampullary adenomas remains complex. While pancreaticoduodenectomy is standard for adenocarcinoma, less invasive options like transduodenal or endoscopic ampullectomy offer lower risks but require careful margin assessment and surveillance for recurrence.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Gastrointestinal Endoscopy
Background:
- Ampullary adenomas are rare neoplasms with unclear management guidelines.
- Adenocarcinoma necessitates pancreaticoduodenectomy (PD), while benign adenomas have multiple treatment options.
- Less invasive procedures like transduodenal ampullectomy (AMP) and endoscopic ampullectomy (EA) have lower morbidity but raise concerns about resection margins and recurrence.
Purpose of the Study:
- To review the management strategies for adenomatous lesions of the ampulla of Vater.
- To discuss the risks and benefits of different treatment modalities.
- To highlight the importance of accurate diagnosis and complete resection.
Main Methods:
- Review of current literature on ampullary adenoma management.
- Comparison of surgical (PD, AMP) and endoscopic (EA) resection techniques.
- Discussion of diagnostic challenges, including biopsy and intraoperative frozen sections.
Main Results:
- Preoperative biopsies have high false-negative rates for malignancy.
- Intraoperative frozen section is crucial for AMP, guiding conversion to PD if carcinoma is found.
- Complete resection is the primary goal for all treatment modalities, though the gold standard for benign adenomas is not definitively established.
Conclusions:
- Management decisions for ampullary adenomas depend on whether the lesion is benign or malignant.
- Less invasive AMP and EA require vigilant surveillance due to recurrence risk.
- Adjuvant chemoradiation has a limited role, and palliative options exist for advanced disease.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
